Characterizing The Role of NPAS1 in Neurodegenerative Diseases

Target Name: NPAS1

NCBI ID: G4861

NPAS1

Characterizing The Role of NPAS1 in Neurodegenerative Diseases

NPAS1 (bHLHe11) is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a key regulator of neural stem cell proliferation and has been implicated in a number of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.

Recent studies have identified NPAS1 as a potential drug target (or biomarker) for a number of neurodegenerative diseases, due to its unique structure and its ability to interact with certain molecules.

One of the key features of NPAS1 is its ability to interact with the protein known as \"TAZ,\" which is a key regulator of neurodegenerative diseases. TAZ is known to play a role in the production of amyloid, a hallmark of Alzheimer's disease, and is thought to contribute to the development and progression of neurodegenerative diseases.

In addition to its interaction with TAZ, NPAS1 has also been shown to interact with the protein known as \" parkin,\" which is also thought to be involved in the development and progression of neurodegenerative diseases.

These interactions between NPAS1 and TAZ and parkin suggest that NPAS1 may be a useful target for the development of new treatments for neurodegenerative diseases.

One way that researchers are studying NPAS1 is to use techniques such as RNA interference and live cell imaging to knockdown or activate the expression of NPAS1 and to determine how this affects the behavior and physiology of neural stem cells. These studies have shown that NPAS1 plays a critical role in the regulation of neural stem cell proliferation and that it is involved in a number of important processes that are involved in the development and progression of neurodegenerative diseases.

Another way that researchers are studying NPAS1 is to use techniques such as mass spectrometry and biochemical assays to determine the structure and function of NPAS1. These studies have shown that NPAS1 is a complex protein that is composed of multiple domains, including an N-terminus that is involved in its localization to the endoplasmic reticulum, a transmembrane domain that is involved in its regulation of neural stem cell proliferation, and a C-terminus that is involved in its interaction with TAZ and parkin.

While the exact mechanism by which NPAS1 promotes neurodegenerative diseases is not yet fully understood, it is thought to be involved in the regulation of neural stem cell proliferation and the production of amyloid, which is a hallmark of Alzheimer's disease.

In conclusion, NPAS1 is a protein that has been shown to be involved in a number of important processes that are involved in the development and progression of neurodegenerative diseases. Its unique structure and its ability to interact with certain molecules make it an attractive target for the development of new treatments for these diseases. Further research is needed to fully understand the exact mechanism by which NPAS1 promotes neurodegenerative diseases and to develop effective treatments.

Protein Name: Neuronal PAS Domain Protein 1

Functions: May control regulatory pathways relevant to schizophrenia and to psychotic illness. May play a role in late central nervous system development by modulating EPO expression in response to cellular oxygen level (By similarity). Forms a heterodimer that binds core DNA sequence 5'-TACGTG-3' within the hypoxia response element (HRE) leading to transcriptional repression on its target gene TH (By similarity)

The "NPAS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NPAS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets